Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
28.26
-0.56 (-1.94%)
Feb 21, 2025, 4:00 PM EST - Market closed
Artivion Revenue
Artivion had revenue of $95.78M in the quarter ending September 30, 2024, with 9.02% growth. This brings the company's revenue in the last twelve months to $384.90M, up 13.29% year-over-year. In the year 2023, Artivion had annual revenue of $354.00M with 12.82% growth.
Revenue (ttm)
$384.90M
Revenue Growth
+13.29%
P/S Ratio
3.04
Revenue / Employee
$256,599
Employees
1,500
Market Cap
1.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.00M | 40.22M | 12.82% |
Dec 31, 2022 | 313.79M | 14.95M | 5.00% |
Dec 31, 2021 | 298.84M | 45.61M | 18.01% |
Dec 31, 2020 | 253.23M | -23.00M | -8.32% |
Dec 31, 2019 | 276.22M | 13.38M | 5.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
AORT News
- 11 days ago - Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 26 days ago - Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting - PRNewsWire
- 2 months ago - US medical device giant Artivion says hackers stole files during cybersecurity incident - TechCrunch
- 2 months ago - Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - PRNewsWire
- 3 months ago - Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Artivion Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Artivion to Participate in Upcoming Investor Conferences - PRNewsWire
- 4 months ago - Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - PRNewsWire